Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $829.8800 (0.63%) ($829.8800 - $829.8800) on Fri. Sep. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.73% (three month average) | RSI | 60 | Latest Price | $829.8800(0.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN declines -0.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(67%) IBB(61%) DIA(55%) XLF(55%) SDY(52%) | Factors Impacting REGN price | REGN will decline at least -0.865% in a week (0% probabilities). VXX(-45%) VIXM(-41%) TBT(-20%) USO(-18%) GLD(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.865% (StdDev 1.73%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $825.19(0.57%) | 10 Day Moving Average | $827.64(0.27%) | 20 Day Moving Average | $823.73(0.75%) | To recent high | -1.8% | To recent low | 19.9% | Market Cap | $87.991b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |